Scarica l'app Stockscreener
2.0464
4.62%
0.0964
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.95
Aprire:
$1.92
Volume 24 ore:
71,955
Relative Volume:
0.93
Capitalizzazione di mercato:
$96.13M
Reddito:
-
Utile/perdita netta:
$-9.51M
Rapporto P/E:
-8.1856
EPS:
-0.25
Flusso di cassa netto:
$-10.96M
1 W Prestazione:
+11.78%
1M Prestazione:
+14.61%
6M Prestazione:
+46.76%
1 anno Prestazione:
+9.68%
Intervallo 1D:
$1.92
$2.05
Intervallo di 1 settimana:
$1.70
$2.05
Portata 52W:
$1.12
$2.55
Medicinova Inc Stock (MNOV) Company Profile
Nome
Medicinova Inc
Settore
Industria
Telefono
858-373-1500
Indirizzo
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Confronta MNOV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| MNOV | 2.049 | 96.13M | 0 | -9.51M | -10.96M | -0.25 |
| VRTX | 450.30 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 747.35 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.08 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.36 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.34 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-03-10 | Iniziato | Maxim Group | Buy |
| 2019-03-25 | Ripresa | B. Riley FBR | Buy |
| 2018-03-28 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-04-18 | Iniziato | Credit Suisse | Outperform |
| 2013-01-04 | Reiterato | Ladenburg Thalmann | Buy |
| 2012-05-24 | Downgrade | MLV & Co | Buy → Hold |
| 2011-10-18 | Reiterato | MLV Capital | Buy |
| 2011-06-22 | Iniziato | Global Hunter Securities | Buy |
| 2010-05-12 | Iniziato | Wedbush | Outperform |
| 2008-11-12 | Reiterato | Ladenburg Thalmann | Buy |
| 2008-05-15 | Iniziato | Rodman & Renshaw | Mkt Outperform |
| 2007-07-09 | Iniziato | Punk, Ziegel & Co | Buy |
Mostra tutto
Medicinova Inc Borsa (MNOV) Ultime notizie
MediciNova reports progress in ALS and Long COVID trials - Investing.com
MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders - GlobeNewswire
MediciNova Partners with NIH for ALS Trial, Reports $42.3M Cash Position | MNOV Stock News - StockTitan
StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV) - Defense World
MediciNova (NASDAQ:MNOV) Coverage Initiated at StockNews.com - MarketBeat
MediciNova Receives Notice of Allowance from United States - GlobeNewswire
MediciNova Secures Key Patent for Diabetes Treatment MN-001 Through 2042 | MNOV Stock News - StockTitan
MediciNova stock hits 52-week high at $2.17 amid growth - Investing.com India
MediciNova: Q3 Earnings Snapshot - New Haven Register
3 US Penny Stocks With Market Caps Over $40M To Consider - Simply Wall St
MediciNova stock hits 52-week high at $2.17 amid growth By Investing.com - Investing.com UK
MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis - The Manila Times
MediciNova Secures Major Settlement from Sanofi-Novartis Litigation, Boosts Clinical Pipeline | MNOV Stock News - StockTitan
Idiopathic Pulmonary Fibrosis Management Market Share and Size Report 2024-2031 - InsightAce Analytic
MediciNova (NASDAQ:MNOV shareholders incur further losses as stock declines 11% this week, taking five-year losses to 80% - Simply Wall St
MediciNova (NASDAQ:MNOV) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com - MarketBeat
TSX Buyback Index (TXBB) QuotePress Release - The Globe and Mail
Idiopathic Pulmonary Fibrosis Market Is Booming Worldwide - openPR
MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com - Defense World
StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - MarketBeat
MediciNova (NASDAQ:MNOV) Shares Cross Above Two Hundred Day Moving Average – Should You Sell? - Defense World
MediciNova (NASDAQ:MNOV) Stock Price Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Clean Harbors (CLH-N) QuotePress Release - The Globe and Mail
MediciNova Announces Update of Phase 2/3 Clinical Trial of - GlobeNewswire
MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium) - StockTitan
MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com - MarketBeat
MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com - Defense World
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
MediciNova, Inc. (NASDAQ:MNOV) Shares Sold by Dimensional Fund Advisors LP - Defense World
Type 1 Diabetes Market Report 2034: Epidemiology Data, Pipeline - openPR
MediciNova (NASDAQ:MNOV) shareholders have endured a 73% loss from investing in the stock five years ago - Yahoo Finance
MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
MNOV: MN-166 to be Evaluated in NIH-Sponsored Expanded Access Trial in ALS - Smartkarma
MNOVMedicinova, Inc. Latest Stock News & Market Updates - StockTitan
Short Interest in MediciNova, Inc. (NASDAQ:MNOV) Rises By 19.3% - MarketBeat
MediciNova to Support NIH-Funded Expanded Access Clinical - GlobeNewswire
MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS) - StockTitan
MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving Average of $1.42 - MarketBeat
Amyotrophic Lateral Sclerosis Pipeline Insights, Treatment Drugs, Clinical Trials, and Companies 2024 - The Globe and Mail
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Stockhouse Publishing
Insigneo Advisory Services LLC Has $6.10 Million Stock Position in Mastercard Incorporated (NYSE:MA) - Defense World
Intech Investment Management LLC Takes Position in MSA Safety Incorporated (NYSE:MSA) - MarketBeat
Minerals Technologies (NYSE:MTX) Upgraded at StockNews.com - MarketBeat
Monroe Capital (NASDAQ:MRCC) Stock Crosses Above 200 Day Moving Average of $7.49 - MarketBeat
MARXU stock soars to all-time high of $12.15 amid market optimism - Investing.com Australia
Marcus (NYSE:MCS) Upgraded by StockNews.com to Hold - Defense World
Mistras Group senior EVP sells over $349k in company stock - Investing.com
Contact Levi & Korsinsky by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc.(MGNX) - Stockhouse Publishing
Summit Trail Advisors LLC Buys 403 Shares of Moderna, Inc. (NASDAQ:MRNA) - Defense World
MacroGenics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationMGNX - Longview News-Journal
Medicinova Inc Azioni (MNOV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.80%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):